CD5 and B-cell chronic lymphocytic leukemia: To examine if CD5 downmodulation can enhance sensitivity to chemotherapy, CLL PBMCs from patients P3 and P4 transfected with PNA or scrambled PNA were treated with the chemotherapic drug fludarabine.